Stepan Overview
- Year Founded
-
1932
- Status
-
Public
- Employees
-
2,328
- Stock Symbol
-
SCL
- Investments
-
22
- Share Price
-
$66.05
- (As of Wednesday Closing)
Stepan General Information
Description
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.
Contact Information
Website
www.stepan.comCorporate Office
- 1101 Skokie Boulevard
- Suite 500
- Northbrook, IL 60062
- United States
Corporate Office
- 1101 Skokie Boulevard
- Suite 500
- Northbrook, IL 60062
- United States
Stepan Stock Performance
As of 18-Nov-2026, Stepan’s stock price is $66.05. Its current market cap is $1.5B with 22.7M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $66.05 | $65.79 | $42.28 - $72.67 | $1.5B | 22.7M | 152K | $0.19 |
Stepan Financials Summary
As of 30-Sep-2026, Stepan has a trailing 12-month revenue of $2.53B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,996,733 | 1,660,216 | 2,052,579 | 2,712,370 |
| Revenue | 2,534,658 | 2,332,114 | 2,180,274 | 2,325,768 |
| EBITDA | 153,444 | 208,060 | 186,818 | 165,832 |
| Net Income | 4,322 | 46,895 | 50,370 | 40,204 |
| Total Assets | 2,390,397 | 2,357,702 | 2,304,648 | 2,363,354 |
| Total Debt | 676,491 | 676,050 | 682,831 | 712,172 |
Stepan Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Stepan Comparisons
Industry
Financing
Details
Stepan Competitors (33)
One of Stepan’s 33 competitors is Huntsman, a Formerly PE-Backed company based in The Woodlands, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Huntsman | Formerly PE-Backed | The Woodlands, TX | ||||
| Celanese | Formerly PE-Backed | Irving, TX | ||||
| Evonik Industries | Formerly PE-Backed | Essen, Germany | ||||
| Wanhua Chemical | Corporation | Yantai, China | ||||
| Solvay | Corporation | Brussels, Belgium |
Stepan Patents
Stepan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026232091-A1 | Methods for treating citrus trees with rhamnolipids | Pending | 01-May-2025 | ||
| WO-2026198444-A1 | Fatty acid triglycerides for cognitive health | Pending | 17-Mar-2025 | ||
| WO-2026165466-A1 | Concentrated surfactant compositions for forming a structured surfactant system | Pending | 03-Feb-2025 | ||
| WO-2026122562-A1 | Rhamnolipids for standard of care wound healing | Pending | 02-Dec-2024 | ||
| WO-2026117708-A1 | Rhamnolipids for biofilm control during wound closure | Pending | 26-Nov-2024 | A61K31/7028 |
Stepan Signals
Stepan Investments & Acquisitions (22)
Stepan’s most recent deal was a Merger/Acquisition with Performanx Specialty Chemicals for . The deal was made on 23-Sep-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Performanx Specialty Chemicals | 23-Sep-2022 | Merger/Acquisition | Specialty Chemicals | ||
| Stepan Company (Fermentation Plant in Lake Providence, Louisiana) | 02-Feb-2021 | Corporate Asset Purchase | Buildings and Property | ||
| INVISTA (Aromatic Polyester Polyol Business) | 29-Jan-2021 | Merger/Acquisition | Specialty Chemicals | ||
| Clariant (Anionic Surfactant Business in Santa Clara, Mexico) | 17-Sep-2020 | Merger/Acquisition | Other Chemicals and Gases | ||
| NatSurFact | 13-Mar-2020 | Merger/Acquisition | Personal Products |
Stepan ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
32.83 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Chemicals
Industry
of 503
Rank
Percentile
Specialty Chemicals
Subindustry
of 165
Rank
Percentile
Stepan Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Stepan Philippines Quaternaries |
Stepan FAQs
-
When was Stepan founded?
Stepan was founded in 1932.
-
Where is Stepan headquartered?
Stepan is headquartered in Northbrook, IL.
-
What is the size of Stepan?
Stepan has 2,328 total employees.
-
What industry is Stepan in?
Stepan’s primary industry is Multi-line Chemicals.
-
Is Stepan a private or public company?
Stepan is a Public company.
-
What is Stepan’s stock symbol?
The ticker symbol for Stepan is SCL.
-
What is the current stock price of Stepan?
As of 18-Nov-2026 the stock price of Stepan is $66.05.
-
What is the current market cap of Stepan?
The current market capitalization of Stepan is $1.5B.
-
What is Stepan’s current revenue?
The trailing twelve month revenue for Stepan is $2.53B.
-
Who are Stepan’s competitors?
Huntsman, Celanese, Evonik Industries, Wanhua Chemical, and Solvay are some of the 33 competitors of Stepan.
-
What is Stepan’s annual earnings per share (EPS)?
Stepan’s EPS for 12 months was $0.19.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process